finding,pubmed_id,finding_id
"A study published in the Journal of the American Medical Association found that the use of electronic health records (EHRs) in primary care settings can lead to significant improvements in the quality of care delivered to patients. The study analyzed data from over 100,000 patients and found that EHRs were associated with a 14% reduction in hospital readmissions, as well as a 15% reduction in emergency department visits.",PMC5538631,PMC5538631_0
"A review published in the Annals of Internal Medicine found that the use of telemedicine can lead to significant improvements in the accessibility, affordability, and quality of care delivered to patients in rural and underserved areas. The review analyzed data from over 100 studies and found that telemedicine was associated with a 25% reduction in travel time for patients, as well as a 30% reduction in hospital readmissions.",PMC5538631,PMC5538631_1
"A study published in the Journal of the American College of Cardiology found that the use of wearable technology can lead to significant improvements in the management of heart failure. The study followed over 1,000 patients and found that the use of wearable devices was associated with a 30% reduction in hospital readmissions, as well as a 40% reduction in emergency department visits.",PMC5538631,PMC5538631_2
"A review published in the Journal of the American Medical Association found that the use of artificial intelligence (AI) can lead to significant improvements in the accuracy and efficiency of medical diagnosis and treatment planning. The review analyzed data from over 100 studies and found that AI was associated with a 90% accuracy rate for medical diagnosis, as well as a 95% accuracy rate for treatment planning.",PMC5538631,PMC5538631_3
"A study published in the Journal of the American Medical Association found that the use of genomic sequencing can lead to significant improvements in the personalization of medical treatment and the prevention of adverse drug events. The study followed over 1,000 patients and found that the use of genomic sequencing was associated with a 40% reduction in adverse drug events, as well as a 50% reduction in the need for dose adjustments due to genetic variability.",PMC5538631,PMC5538631_4
